Le Lézard
Classified in: Health
Subjects: SVY, POL, AVO

ACC Calls Upon Global Leaders To Take Action Against IARC Over Deliberate Manipulation Of Data


WASHINGTON, Oct. 19, 2017 /PRNewswire-USNewswire/ -- Cal Dooley, President and CEO of the American Chemistry Council (ACC) issued the following statement on the Reuters investigation into the International Agency for Cancer Research's (IARC) controversial Monograph 112.

"Today's Reuters report undermines IARC's conclusions about glyphosate, but it also raises troubling new evidence that IARC has shown a lack of objectivity, credibility and integrity. The deliberate omission of critical evidence demonstrated by this news report should cause deep concern among all individuals and institutions who believe that dispassionate science should be the great truth-teller and equalizer in heated policy debates. In this case it appears that the science was truthful, but IARC was not.

"IARC's rewriting of the glyphosate Monograph to remove conclusions that glyphosate did not cause cancer in animals is a serious violation of public trust. Considering earlier revelations that a major study exonerating glyphosate was withheld from the Monograph working group, there is ample evidence that the IARC's classification of glyphosate is invalid. Any policy decisions that have been based on IARC's glyphosate findings should be reexamined as they can no longer be justified. 

"This incident also calls into question the credibility of other Monographs because it is unknown whether this was an isolated incident or evidence of a widespread practice. IARC's refusal to discuss the allegations and its warning to Monograph participants that they should not comment on deliberations and editing related to the glyphosate Monograph creates further suspicion that IARC has something to hide.

"ACC and others have called for reform of IARC based on a persistent lack of transparency and widespread conflicts of interest within the Monographs program. These are important critiques of IARC policies and procedures that must be addressed. However today's allegations of blatant manipulation of information and disregard for clear scientific evidence supports the urgent need for a full investigation by an unaffiliated third party. Ultimately, the leadership and staff of IARC must be held accountable.

"I urge all countries and organizations that provide funding to IARC to join me in the call to investigate the Monographs program and to implement reforms."

To learn more visit campaignforaccuracyinpublichealthresearch.com

http://www.americanchemistry.com

The American Chemistry Council (ACC) represents the leading companies engaged in the business of chemistry. ACC members apply the science of chemistry to make innovative products and services that make people's lives better, healthier and safer. ACC is committed to improved environmental, health and safety performance through Responsible Care®; common sense advocacy designed to address major public policy issues; and health and environmental research and product testing. The business of chemistry is a $768 billion enterprise and a key element of the nation's economy. It is among the largest exporters in the nation, accounting for fourteen percent of all U.S. goods exports. Chemistry companies are among the largest investors in research and development. Safety and security have always been primary concerns of ACC members, and they have intensified their efforts, working closely with government agencies to improve security and to defend against any threat to the nation's critical infrastructure.

 

SOURCE American Chemistry Council


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: